USPTO serial 90354581
DRAGEN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 8, 2022
- Examiner
- CUMMINS, LANCE E
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with DRAGEN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Susan M. Natland
Susan M. Natland Baker & Hostetler LLP600 Anton Blvd, Suite 900Costa Mesa, CA 92626-7221United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Computer hardware with preinstalled software and downloadable software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data, for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer hardware with preinstalled software and downloadable software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data, for use with population genetic sequencing, neonatal intensive care unit (NICU) and genetic disease research, genetic cancer research, agrigenomics, and clinical and translational research, all in the field of genomics; Computer hardware with preinstalled software and downloadable software for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer hardware with preinstalled software and downloadable software for analyzing next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer hardware with preinstalled software and downloadable software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing digital files in the field of genomics; Computer hardware with preinstalled software and downloadable software for processing, visualizing, storing, sharing, and manipulating next- generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Microprocessors for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Data processing apparatus for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cards with integrated circuits for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer chips for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Next-generation sequencing bioinformatics data processor for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Encoded electronic chip cards containing programming used for DNA sequencing; Downloadable electronic publications in the nature of whitepapers in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Downloadable electronic publications in the nature of reports in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Integrated circuits for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Apparatus and instruments for scientific research in laboratories, namely, genetic sequencers; Laboratory devices for detecting genetic sequences; Diagnostic apparatus for the detection of pathogens for laboratory or research use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Scientific apparatus and instruments for measuring relative DNA, RNA, and protein for use in genetic analysis; Apparatus for DNA and RNA testing for genetic research and scientific purposes; Apparatus and instruments for scientific research in laboratories, namely, genetic sequencers, for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; DNA chips | ACTIVE | Apr 30, 2015 |
| 042 | Providing on-line non-downloadable computer software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing on-line non-downloadable computer software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use with population genetic sequencing, neonatal intensive care unit (NICU) and genetic disease research, cancer research, agrigenomics, and clinical and translational research, all in the field of genomics; Providing on-line non-downloadable computer software for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing on-line non-downloadable computer software for analyzing next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing on-line non-downloadable computer software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing digital files in the field of genomics; Providing on-line non-downloadable computer software for processing, visualizing, storing, sharing, and manipulating next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing on-line non-downloadable computer software that enables users to store, access, manage, analyze and share data in the field of genomics; Software as a service (SaaS) services featuring software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Platform as a service (PaaS) featuring computer software platforms for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services featuring software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use with population genetic sequencing, neonatal intensive care unit (NICU) and genetic disease research, genetic cancer research, agrigenomics, and clinical and translational research, all in the field of genomics; Platform as a service (PaaS) featuring computer software platforms for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing data for use with population genetic sequencing, neonatal intensive care unit (NICU) and genetic disease research, genetic cancer research, agrigenomics, and clinical and translational research, all in the field of genomics; Software as a service (SaaS) services featuring software for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Platform as a service (PaaS) featuring computer software platforms for analysis of sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services featuring software for analyzing next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Platform as a service (PaaS) featuring computer software platforms for analyzing next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services featuring software for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing digital files in the field of genomics; Platform as a service (PaaS) featuring computer software platforms for capturing, storing, accessing, displaying, sharing, compressing, migrating, and managing digital files in the field of genomics; Software as a service (SaaS) services featuring software for processing, visualizing, storing, sharing, and manipulating next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Platform as a service (PaaS) featuring computer software platforms for processing, visualizing, storing, sharing, and manipulating next-generation sequencing data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Software as a service (SaaS) services featuring software for collecting, storing, analyzing, sharing and reporting biological, genetic, clinical, medical, and diagnostic information, and for sample tracking and managing projects, laboratory workflow and data, all of the foregoing for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Platform as a service (PaaS) featuring computer software platforms for collecting, storing, analyzing, sharing and reporting biological, genetic, clinical, medical, and diagnostic information, and for sample tracking and managing projects, laboratory workflow and data, all of the foregoing for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing scientific analysis for scientific research purposes in the field of next-generation sequencing in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing scientific analysis of genomic data for scientific research purposes; Technical support services, namely, troubleshooting of computer software problems and providing software updates, enhancements and modifications for software and hosted software in the field of nucleic acid sequencing, genotyping, genetic testing, and genetics; Technical support services, namely, remote and on-site infrastructure management services for monitoring, administration and management of cloud computing IT and application systems in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; DNA analysis services for scientific and research purposes in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Medical research in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Nucleic acid sequencing and analysis services for scientific and research purposes; Genome sequencing and analysis services for scientific and research purposes; Genetic analysis and reporting services for scientific research purposes; Consultation services for the purposes of clinical research, medical research and scientific research, all in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Scientific laboratory services in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Medical laboratory services in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Development of automated laboratory equipment and systems, and computer hardware for collecting, storing, analyzing, sharing and reporting biological, genetic, clinical, medical, and diagnostic information, and for sample tracking and managing projects, laboratory workflow and data to the order and specification of others, all of the foregoing in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Genetic DNA and RNA analysis and reporting services in the nature of providing reports in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics for scientific research purposes; Consulting services for others relating to data management, namely, electronic data storage, and information technology infrastructure development in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Biological material analysis services in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Hosting an online network service that enables users to store, analyze and share data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Installation and maintenance of computer software and database applications for others for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Updating of computer software for others in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud hosting provider services and onsite infrastructure management services for storing, analyzing and sharing information in the form of electronic data in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing an online network service that enables users to store, access, manage, analyze and share data for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing technology consulting services for others relating to electronic data management and information technology infrastructure development in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Design and preparation of databases for others for collecting, storing, analyzing, and reporting biological information in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Database design and development in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Computer diagnostic services in analyzing and sequencing nucleic acids and other biological molecules in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud computing featuring software for analyzing and sequencing nucleic acids and other biological molecules, for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing temporary use of on-line non-downloadable cloud computing software for analyzing and sequencing nucleic acids and other biological molecules in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing on-line non-downloadable computer search engine software in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online non-downloadable computer software for the custom design and ordering of assays, agents, enzymes, nucleotides, nucleic acids, buffers, chemical preparations, biological preparations, and reagents, all in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing an online portal featuring educational information in the fields of medical and scientific research about nucleic acid sequencing, genotyping, genetic testing, and genetics; Scientific research consulting services in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Cloud computing featuring software for use in database management, for use in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Providing online computer databases featuring information based on the results of genetic testing for scientific research purposes; Software as a service (SaaS) services featuring software for use in data management, data compression, data migration, data storage, data analysis, and report generation, all in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics; Platform as a service (PaaS) featuring computer software platforms for use in data management, data compression, data migration, data storage, data analysis, and report generation, all in the fields of nucleic acid sequencing, genotyping, genetic testing, and genetics | ACTIVE | Aug 30, 2017 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 29, 2025 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Oct 29, 2025 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 29, 2025 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 29, 2025 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Oct 29, 2025 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Oct 29, 2025 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 8, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 8, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 6, 2022 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Oct 5, 2022 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Sep 23, 2022 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Sep 23, 2022 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 13, 2022 | IUAF | USE AMENDMENT FILED | — |
| Sep 13, 2022 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 15, 2022 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 18, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 18, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 29, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 13, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 9, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 9, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Dec 9, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 23, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 22, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 22, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 28, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 28, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 19, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 8, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 5, 2020 | NWAP | NEW APPLICATION ENTERED | — |